Direct-to-consumer virtual care company Hims & Hers is partnering with Novo Nordisk to allow Americans to access a bundled offering that includes the pharma giant's obesity drug Wegovy and a Hims & Hers membership starting at $599 per month.
Hims & Hers members will have direct access to NovoCare Pharmacy, an offering through Novo Nordisk that allows cash-paying individuals without...
Editor's note: This article has been updated with context from Lark Health.
Chronic disease prevention and management platform Lark Health announced it will be available through CVS Caremark's Point Solutions Management program.
CVS Caremark customers will have the ability to access Lark's coaching programs, including the company's GLP-1 cost containment and obesity management offerings, through...
Employee health benefits management platform Collective Health is partnering with digital healthcare platform and weight loss company Noom's enterprise division, Noom Health, to deliver Collective Health + Noom Med with SmartRx, an enterprise weight management platform with an integrated GLP-1 drug program that will be accessible to Collective Health employer customers.
The partnership will...
Direct-to-consumer virtual care company Hims & Hers is receiving backlash to its 60-second commercial dubbed "Sick of the System" that ran during the Super Bowl on Fox.
The ad states that "obesity is America's deadliest epidemic" and claims that "something is broken, and it's not our bodies; it's the system." It then says the $160 billion weight loss industry "feeds on our failure."
It says...
Digital weight loss company Noom has confirmed it laid off a portion of its staff.
"In an effort to build a more efficient business centered around the needs of our customers, we made the difficult decision to reduce a portion of our workforce," a company spokesperson told MobiHealthNews.
"This is not a decision we made lightly, and we are committed to providing our impacted colleagues with...
DarioHealth, a digital chronic condition management platform, announced it expanded its GLP-1 offering with prescribing capabilities, a move the company said will help it capture a larger share of the weight-loss market space.
The company also announced a collaboration with MediOrbis, a multi-specialty digital health provider, to add prescribing capabilities to Dario’s GLP-1 behavior change...
Allurion Technologies, a weight-loss platform, launched AllurionMeds to give patients GLP-1 medications for weight loss combined with its AI-enabled Coach Iris platform.
The company aims to advance long-term weight maintenance through virtual access to dieticians and a connected smart scale that measures not just weight, but also muscle and bone mass.
Along with Coach Iris, patients will have...
Direct-to-consumer virtual care company Hims & Hers Health reported a 77% year-over-year increase in revenue from $226.7 million in the third quarter of 2023 to $401.6 million in Q3 2024.
The San Francisco-based company reported a net income for the third quarter of $75.6 million compared to a net loss of $7.6 million in the same period last year. It attributes the net income in Q3 to a $60....
Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight-loss management.
The San Francisco-based company, which launched its weight-loss program in December, said users will now have access to generic and 503B compounded injectable medications and oral medication kits...
New Jersey-based nutritional supplements supplier The Vitamin Shoppe announced its launching of Whole Health Rx, a telehealth service that will connect users with providers to help them access GLP-1 medications for weight management.
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, but have recently become more popular for managing...
